Pringsheim Tamara

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. pmc Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
    Farnaz Amoozegar
    Calgary Headache Assessment and Management Program, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada
    Patient Prefer Adherence 3:251-8. 2009
  2. pmc Prenatal risk factors for Tourette Syndrome: a systematic review
    Ting Kuang Chao
    Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
    BMC Pregnancy Childbirth 14:53. 2014
  3. ncbi request reprint Social behavior and comorbidity in children with tics
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Electronic address
    Pediatr Neurol 49:406-10. 2013
  4. doi request reprint Tourette syndrome and other tic disorders of childhood
    Pringsheim Tamara
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Alberta Children s Hospital, Calgary, Canada Electronic address
    Handb Clin Neurol 112:853-6. 2013
  5. ncbi request reprint Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Can J Psychiatry 57:722-7. 2012
  6. ncbi request reprint Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta
    Can J Psychiatry 57:133-43. 2012
  7. doi request reprint The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Mov Disord 27:1083-91. 2012
  8. doi request reprint The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Canada
    J Child Adolesc Psychopharmacol 21:537-43. 2011
  9. ncbi request reprint The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Alberta
    Can J Psychiatry 56:630-4. 2011
  10. pmc Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth
    Tamara Pringsheim
    The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children CAMESA Guideline Project
    J Can Acad Child Adolesc Psychiatry 20:218-33. 2011

Detail Information

Publications14

  1. pmc Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
    Farnaz Amoozegar
    Calgary Headache Assessment and Management Program, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada
    Patient Prefer Adherence 3:251-8. 2009
    ..The published clinical trials included in this systematic review are subject to bias due to the open-label nature of preference trials and the doses chosen for comparison in head-to-head trials...
  2. pmc Prenatal risk factors for Tourette Syndrome: a systematic review
    Ting Kuang Chao
    Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
    BMC Pregnancy Childbirth 14:53. 2014
    ..A systematic review and qualitative analysis were performed to provide a broad view of the association between pre- and perinatal factors and TS...
  3. ncbi request reprint Social behavior and comorbidity in children with tics
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Electronic address
    Pediatr Neurol 49:406-10. 2013
    ..To examine the characteristics of children with coexisting tics and autism spectrum disorder and determine if children with tics have deficits in social behavior...
  4. doi request reprint Tourette syndrome and other tic disorders of childhood
    Pringsheim Tamara
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Alberta Children s Hospital, Calgary, Canada Electronic address
    Handb Clin Neurol 112:853-6. 2013
    ..As treatment for tics does not alter the natural history of the disorder, it is only recommended if the tics are causing disability. Effective treatments to suppress tics include α-adrenergic agonists and antipsychotic medications...
  5. ncbi request reprint Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Can J Psychiatry 57:722-7. 2012
    ..Increases are mainly attributable to treatment of disruptive behaviour disorders (DBDs). Our objective was to review the evidence regarding the efficacy of SGAs for DBDs in youth...
  6. ncbi request reprint Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta
    Can J Psychiatry 57:133-43. 2012
    ..However, when tics are more distressing and interfering, the need for tic suppression to improve quality of life is stronger, and patients and clinicians may be more willing to accept the risks of pharmacotherapy...
  7. doi request reprint The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Mov Disord 27:1083-91. 2012
    ..HD is a devastating neurodegenerative disorder with a higher prevalence in Europe, North America, and Australia than in Asia. The difference in prevalence of this genetic disorder can be largely explained by huntingtin gene haplotypes...
  8. doi request reprint The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Canada
    J Child Adolesc Psychopharmacol 21:537-43. 2011
    ..To describe the frequency and trends of use of antipsychotics in Canadian children and adolescents from 2005 to 2009...
  9. ncbi request reprint The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Alberta
    Can J Psychiatry 56:630-4. 2011
    ..To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in Canada from 2005 to 2009...
  10. pmc Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth
    Tamara Pringsheim
    The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children CAMESA Guideline Project
    J Can Acad Child Adolesc Psychiatry 20:218-33. 2011
    ..These medications have the potential to cause major metabolic and neurological complications with chronic use...
  11. doi request reprint Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials
    Tamara Pringsheim
    University of Calgary, Calgary, AB, Canada
    Drug Saf 34:651-68. 2011
    ..Given the demonstrated metabolic and neurological adverse effects seen in adult patients on these medications, detailed evaluation of the risk for these adverse effects in children is appropriate...
  12. doi request reprint Complications of antipsychotic therapy in children with tourette syndrome
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    Pediatr Neurol 43:17-20. 2010
    ..Neurologic complications are uncommon, which is likely attributable to the primary use of atypical antipsychotics in this setting...
  13. doi request reprint Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    J Dev Behav Pediatr 30:115-21. 2009
    ..Low birth weight is a known risk factor for ADHD. The objective of the study was to assess the association between pre- and perinatal morbidity and the comorbid diagnosis of ADHD in children with TS...
  14. ncbi request reprint Canadian Headache Society guideline for migraine prophylaxis
    Tamara Pringsheim
    University of Calgary and the Hotchkiss Brain Institute, Calgary, AB, Canada
    Can J Neurol Sci 39:S1-59. 2012
    ..This guideline is focused on patients with episodic migraine (headache on ≤ 14 days a month)...